User profiles for Panayiota L. Papasavva

Panayiota Papasavva

The Cyprus Institute of Neurology and Genetics
Verified email at cing.ac.cy
Cited by 210

Distinct miRNA signatures and networks discern fetal from adult erythroid differentiation and primary from immortalized erythroid cells

PL Papasavva, NY Papaioannou, P Patsali… - International journal of …, 2021 - mdpi.com
MicroRNAs (miRNAs) are small non-coding RNAs crucial for post-transcriptional and
translational regulation of cellular and developmental pathways. The study of miRNAs in …

Context base editing for splice correction of IVSI-110 β-thalassemia

B Naiisseh, PL Papasavva, NY Papaioannou… - … Therapy-Nucleic Acids, 2024 - cell.com
β-Thalassemia is brought about by defective β-globin (HBB [hemoglobin subunit β]) formation
and, in severe cases, requires regular blood transfusion and iron chelation for survival. …

Case report: Rethinking NGS analysis in diagnosing Diamond-Blackfan anemia syndrome

PL Papasavva, K Kaouranis, S Byrou… - Frontiers in …, 2024 - frontiersin.org
Diamond-Blackfan anemia syndrome (DBAS) is a rare inherited bone marrow failure (BMF)
syndrome characterized by erythroid aplasia, congenital malformations, and cancer …

CRISPR editing enables consequential tag-activated MicroRNA-mediated endogene deactivation

PL Papasavva, P Patsali, CC Loucari, R Kurita… - International Journal of …, 2022 - mdpi.com
Molecular therapies and functional studies greatly benefit from spatial and temporal precision
of genetic intervention. We therefore conceived and explored tag-activated microRNA (…

High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis

…, B Naiisseh, PL Papasavva, L Koniali… - Frontiers in Genome …, 2023 - frontiersin.org
Introduction: Genome editing tools, such as CRISPR/Cas, TALE nucleases and, more recently,
double-strand-break-independent editors, have been successfully used for gene therapy …

[HTML][HTML] Combining clinical and molecular data for personalized treatment in acute myeloid leukemia: A machine learning approach

N Karathanasis, PL Papasavva, A Oulas… - Computer Methods and …, 2024 - Elsevier
Background and Objective The standard of care in Acute Myeloid Leukemia patients has
remained essentially unchanged for nearly 40 years. Due to the complicated mutational …

Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by HBBAS3 Gene Addition and Mutation-Specific RNA Interference

…, MI Kostopoulou, NY Papaioannou, PL Papasavva… - Cells, 2023 - mdpi.com
Therapy via the gene addition of the anti-sickling β AS3 -globin transgene is potentially curative
for all β-hemoglobinopathies and therefore of particular clinical and commercial interest. …

Catching them early: Framework parameters and progress for prenatal and childhood application of advanced therapies

…, L Koniali, T Buerki-Thurnherr, PL Papasavva… - Pharmaceutics, 2022 - mdpi.com
Advanced therapy medicinal products (ATMPs) are medicines for human use based on genes,
cells or tissue engineering. After clear successes in adults, the nascent technology now …

Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform

M Papasavva, S Amvrosiou, KM Pilala… - International Journal of …, 2023 - mdpi.com
Cellular and molecular immune components play a crucial role in the development and
perpetuation of human malignancies, shaping anti-tumor responses. A novel immune regulator …

Machine Learning for Predicting Therapeutic Outcomes in Acute Myeloid Leukemia Patients

N Karathanasis, P Papasavva, A Oulas, GM Spyrou - medRxiv, 2024 - medrxiv.org
Background and Objective: The standard of care in Acute Myeloid Leukemia patients has
remained essentially unchanged for nearly 40 years. Due to the complicated mutational …